Yanjie Xiao
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Development of a prognostic prediction model incorporating KDM1B for esophageal squamous cell carcinoma: an integrated transcriptomic and functional analysis.
Journal: Journal of gastrointestinal oncology
Published: March 05, 2026
Metastatic squamous cell carcinoma of unknown primary: a case report and brief literature review.
Journal: Frontiers in oncology
Published: April 17, 2025
Large cell neuroendocrine carcinoma transformation: A novel acquired drug resistance mechanism in colorectal adenocarcinoma.
Journal: Cancer innovation
Published: August 02, 2022
Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane.
Journal: The journal of gene medicine
Published: March 21, 2022
Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma.
Journal: Future oncology (London, England)
Published: March 12, 2021
Phase 1 dose-escalation study of apatinib and irinotecan in esophageal squamous cell carcinoma patients.
Journal: Translational cancer research
Published: July 09, 2020
Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma.
Journal: Cancer management and research
Published: December 18, 2019
Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy.
Journal: Translational cancer research
Published: June 22, 2019
Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study.
Journal: Journal of Cancer
Published: July 20, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026